Italy’s antitrust watchdog AGCM has fined Samsung’s Italian subsidiary a total of over EUR 3 million for “misleading and aggressive commercial practices” and unauthorised collection of personal data following a probe launched after the regulator received complaints from consumer associations Federconsumatori Palermo and the National Consumers Union. Above all, the watchdog said Samsung’s advertising presented a serious lack of information on the nature of the promotion, on the conditions, limitations and procedures to be followed to obtain a promised prize or advantage.
The second aggressive commercial practice denounced by the antitrust body referred to the collection of customer personal data for marketing purposes adopted by Samsung until 15 August 2016. The company was accused of forcing customers to provide a range of personal data to access promotions with the promise of prizes.
In a statement, Samsung completely rejected the AGCM’s findings and said it was considering appealing the fine before the Regional Administrative Court of Lazio, the main Italian administrative court of first instance.
Full Content: Telecom Paper
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Judge Orders Apple to Address Fortnite App Block or Face Court Hearing
May 19, 2025 by
CPI
EU Civil Society Groups and Labor Unions Raise Alarm Over Proposed Changes to GDPR
May 19, 2025 by
CPI
EU Antitrust Regulators Push Back Deadline on UniCredit’s Takeover Bid for Banco BPM
May 19, 2025 by
CPI
Intel Challenges €376 Million EU Fine in Ongoing Antitrust Dispute
May 19, 2025 by
CPI
Red Bull Challenges EU Commission Over Lengthy Antitrust Inspection
May 19, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas